Secnidazole: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Contraindications

Hypersensitivity to secnidazole or other nitroimidazole derivatives. Lactation.

Special Precautions

Children. Pregnancy. Avoid chronic use. Granules are not intended to be dissolved or administered in any liquid. Monitoring Parameters For bacterial vaginosis: Perform culture and susceptibility tests; consult local institutional recommendations before treatment initiation due to antibacterial resistance risks.

Adverse Reactions

Significant: Vulvovaginal candidiasis. Blood and lymphatic system disorders: Moderate leucopenia. Gastrointestinal disorders: Nausea, diarrhoea, abdominal pain, dysgeusia, vomiting, stomatitis, glossitis. Nervous system disorders: Headache. Reproductive system and breast disorders: Vulvovaginal pruritus. Skin and subcutaneous tissue disorders: Urticaria.

Drug Interactions

May increase the effects of oral anticoagulant drugs thus increase the risk of bleeding.

CIMS Class

Antiamoebics / Other Antibiotics / Other Antiprotozoal Agents

ATC Classification

P01AB07 - secnidazole ; Belongs to the class of nitroimidazole derivatives antiprotozoals. Used in the treatment amoebiasis and other protozoal diseases.

Disclaimer: This information is independently developed by CIMS based on secnidazole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com